2025 Delaware Code
Title 16 - Health and Safety
Chapter 30G. Opioid Antagonist Access Program
§ 3003G. Department responsibilities [Effective until July 17, 2028].
(a) The Department shall implement and monitor an Opioid Antagonist Access Program that authorizes public safety personnel and members of the public to receive, carry, and administer an opioid antagonist to an individual experiencing a known or suspected opioid overdose.
(b) The Department shall implement the Opioid Antagonist Access Program by creating written and uniform treatment protocols and care plans for emergency and critical patients statewide that constitute the standing orders for the administration of naloxone under subsection (a) of this section.
(c) In addition to the standing orders for naloxone under subsection (b) of this section, the Department may create written and uniform treatment protocols and care plans for emergency and critical patients statewide that constitute the standing orders for the administration of other opioid antagonists.
(d) Each treatment protocol and standing order for the administration of an opioid antagonist under this section must be approved and signed by 1 of the following:
(1) The State EMS Medical Director.
(2) The Medical Director, Division of Public Health.
(3) Director of the Division of Public Health or, if the Director is not a licensed physician or advanced practice registered nurse, a licensed physician or advanced practice registered nurse designated by the Director and employed by the Division.
(e) The Department shall approve 1 or more training programs in the administration of each opioid antagonist for which there is a standing order under this section.
83 Del. Laws, c. 531, § 1; 84 Del. Laws, c. 92, § 4;
